Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
Conjupro Biotherapeutics, Inc.
Conjupro Biotherapeutics, Inc.
Avacta Life Sciences Ltd
Beijing Biotech
AbbVie
Merck Sharp & Dohme LLC
Pfizer
Seagen Inc.
Zai Lab (Hong Kong), Ltd.
PMV Pharmaceuticals, Inc
Kivu Bioscience Inc.
BeOne Medicines
Akeso
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.
Bristol-Myers Squibb
Neonc Technologies, Inc.
Daiichi Sankyo
AstraZeneca
Eli Lilly and Company
Amgen
Amgen
AstraZeneca
Novartis
Radiopharm Theranostics, Ltd
Puma Biotechnology, Inc.
BioNTech SE
NiKang Therapeutics, Inc.
BioNTech SE
Merck Sharp & Dohme LLC
Tempus AI
Boehringer Ingelheim
MacroGenics
Amgen
SystImmune Inc.
IDEAYA Biosciences
Radiopharm Theranostics, Ltd
Pfizer
Molecular Partners AG
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
SciTech Development, Inc.
VM Oncology, LLC
GV20 Therapeutics
Amgen
Akeso
TCRCure Biopharma Ltd.
DualityBio Inc.
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
MediLink Therapeutics (Suzhou) Co., Ltd.
Nerviano Medical Sciences